EMR Related Analyst Ratings
-
Bernstein Downgrades Emerson (EMR) to Market Perform
-
Canaccord Genuity Starts Emerson (EMR) at Hold
-
Goldman Sachs Resumes Emerson (EMR) at Neutral
-
RBC Capital Starts Emerson (EMR) at Outperform
-
Langenberg & Company Downgrades Emerson (EMR) to Hold
-
Deutsche Bank Upgrades Emerson (EMR) to Buy
-
Morgan Stanley Downgrades Emerson (EMR) to Equalweight
-
BofA/Merrill Lynch Reinstates Emerson (EMR) at Neutral
-
Oppenheimer Downgrades Emerson (EMR) to Perform
-
Fat Dividend Yield, Stock Price Provides Good Entry Point for GE (GE) - Barclays
-
Deutsche Bank Starts Emerson (EMR) at Hold
-
Macquarie Downgrades Emerson (EMR) to Neutral
-
Nomura Trims Numbers on Emerson (EMR) in Light of Choppy Demand
-
Janney Montgomery Scott Starts Emerson (EMR) at Neutral
-
UBS on Electrical Equipment and Multi-Industry: New and Notable (FAST, IR, EMR, LII, CBE, ETN)
-
UPDATE: MKM Partners Downgrades Eaton Corporation (ETN) to Neutral; Risk/Reward Balanced with Slight Concerns
-
Nomura Securities Maintains a 'Buy' on Emerson (EMR); Orders Picking Up
-
Nomura Securities Maintains a 'Buy' on Emerson (EMR); 3-Month Rolling Orders Were +3%
-
Nomura Securities on Industrials: Q2 Preview - Cutting Estimates Across The Board
-
Oppenheimer on Multi-Industry Stocks: Adjusting Estimates and Price Targets on 11 Companies
-
Barclays on U.S. Multi-Industry: Stocks to Own/Avoid Going Into the Quarter
-
Nomura Securities Maintains a 'Buy' on Emerson (EMR); Some Moderation, But Too Much Investor Skepticism
-
Nomura Securities on Emerson (EMR): Valuation Remains Attractive; Invensys Good Fit on Right Terms
-
Barclays on U.S. Multi-Industry: Cutting Estimates: FX and Macro Headwinds
-
Nomura Securities Reiterates a 'Buy' on Emerson (EMR); Management Change Unrelated to Performance
-
Nomura Securities Maintains a 'Buy' on Emerson (EMR); Supporting The Process
-
Nomura Securities Maintains a 'Buy' on Emerson (EMR); Organic Orders Accelerate
-
Nomura Securities on Industrials: Q1 Wrap-Up - Organic Growth is Accelerating Again
-
Nomura Securities Maintains a 'Buy' on Emerson (EMR); F2 Review; Don’t Throw in the Towel Yet
-
Nomura Securities on Industrials: Q1 Preview - Dover (DOV) Still A Top Idea
-
UPDATE - Nomura Securities Upgrades Emerson (EMR) to Buy; Great Company That Is Undervalued
-
Nomura Securities Upgrades Emerson (EMR) to Buy
-
Oppenheimer maintains an 'Outperform' on Emerson (EMR); Transition Tempers Timing, But Backlog Offers Tailwind
-
Nomura Securities on U.S. Industrials: Shifting targets to 2013; Picks Unchanged
-
Nomura Securities Maintains a 'Neutral' on Emerson (EMR); Q1 Review; Investor Meeting Take-aways
-
Nomura Securities Maintains a 'Neutral' on Emerson (EMR); Q1 Review
-
Goldman Sachs Downgrades Emerson (EMR) to Neutral Citing Lack of Catalysts
-
Morgan Stanley Starts Emerson (EMR) at Overweight, Sets $56 Price Target
-
Goldman Sachs Lowers Numbers on Emerson (EMR), Keeps Buy Rating
-
Barclays Maintains an 'Equalweight' on 3M (MMM); Thoughts on Investor Day
-
Barclays on U.S. Multi-Industry: Mid-Quarter Update & Thoughts Post Management Meetings
-
Barclays Maintains an 'Overweight' on Rockwell Automation (ROK); 2011 Investor Day and Stock Comments
-
Barclays on U.S. Multi-Industry: The Seasonality Trade in Industrials
-
Barclays Maintains an 'Overweight' on Rockwell Automation (ROK); F4Q11: Automation Cycle Intact
-
Citi Upgrades Emerson (EMR) to Buy
-
UBS Maintains a 'Neutral' on Emerson (EMR); Positive Outlook Despite Challenging Macro
-
Nomura Securities Maintains a 'Neutral' on Emerson (EMR); Adjusts PT & Estimates
-
Goldman Sachs Lowers Numbers on General Electric (GE) Ahead of Q3 Results
-
Barclays Starts Emerson (EMR) at Equalweight, $55 Price Target
-
BofA/Merrill Lynch Downgrades Emerson (EMR) to Neutral
Back to EMR Stock Lookup
